CC

Casdin Capital Portfolio holdings

AUM $1.61B
1-Year Est. Return 69.26%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+69.26%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$942M
AUM Growth
-$132M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
39
New
Increased
Reduced
Closed

Top Buys

1
+$39.3M
2
+$36.5M
3
+$18.8M
4
CRSP icon
CRISPR Therapeutics
CRSP
+$13.8M
5
ADVM
Adverum Biotechnologies
ADVM
+$13.1M

Top Sells

1
+$51.5M
2
+$8.62M
3
+$8.09M
4
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$6.39M
5
NVTA
Invitae Corporation
NVTA
+$2.92M

Sector Composition

1 Healthcare 92.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$11M 1.17%
+112,500
27
$10M 1.06%
1,095,075
28
$9.78M 1.04%
+190,000
29
$9.72M 1.03%
+500,000
30
$9.5M 1.01%
2,500,000
+1,000,000
31
$9.27M 0.98%
1,455,000
32
$8.19M 0.87%
30,840
-30,840
33
$7.34M 0.78%
97,500
+15,500
34
$7.22M 0.77%
+289,395
35
$5.76M 0.61%
140,000
-115,000
36
$5.64M 0.6%
+571,713
37
$3.35M 0.36%
75,000
38
$2.75M 0.29%
120,000
-10,000
39
– –
-860,000
1
2